Press Releases

Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research

Dolomite Bio launches new hydrogel focused reagent kits, enabling high-throughput encapsulation of cells in hydrogel scaffolds.

Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022

Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.

Antibody-drug Conjugates Manufacturing and Future Focus

ADCs demonstrated great potential for the treatment of cancers, and simultaneously require unique supporting infrastructure to meet biopharmaceutical industry standards for safe, effective, and reliable manufacturing.

Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene

Creative Biogene provides partners with comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments.

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

A New Phase of BOC Sciences Partnership Expansion Unlocked after TIDES USA 2022

BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale.

Huateng Pharma has the capability to rapidly produce key intermediates for antiviral drugs

Huateng Pharma has the capabilities to perform process development and scale-up antiviral drug intermediates, eg. paxlovid intermediates.

Biopharma PEG Supports mRNA Vaccine Delivery with The Production of PEG Derivatives for LNP System

Biopharma PEG provides lab and GMP grade PEG lipids for the LNP systems in mRNA vaccines.

CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues

Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help researchers address some of the long-standing issues in drug development like drug solubility, bioavailability, and dissolution rate.

BOC Sciences: A Robust Isotope Labeling Service Vendor

BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.

Creative Peptides Unveils Product Portfolio of Standard Fmoc/Boc-PNA Monomers

Creative Peptides supplies standard Fmoc- and Boc-PNA monomers that can be ordered in large quantities with high purity, solubility, and reactivity.

Complete Virtual Screening Solutions at BOC Sciences to Unleash Novel Drug Discovery Potential

Today, BOC Sciences released a complete set of virtual screening solutions to help partners maximize the diversity of hits using its ultra-large-scale purchasable compound libraries.

BOC Sciences Unveils Access to Comprehensive Set of PROTAC In Vitro Evaluation Services

BOC Sciences today unveiled access to its comprehensive set of PROTAC in vitro evaluation services for biopharmaceutical clients and partners to expedite their PROTAC development from preclinical studies to clinical trials.

CD ComputaBio Introduces IPA Analysis Service to Speed Up Your Research

DFE Pharma opens its new Center of Excellence in India to provide fast-track formulation services

CD Formulation Offers Forced Degradation Studies

To ensure the safety and efficacy of the drug product, chemical stability is of paramount importance. Earlier this month, CD Formulation announced its decision to launch forced degradation studies to help researchers find ways to promote drug stability.

Alfa Chemistry Catalysts Releases Asymmetric Organocatalysts for Chemical Reactions

As a reliable source for versatile catalysts, Alfa Chemistry Catalysts today announces that it has launched a rich of collection of asymmetric organocatalysts, including chiral amines, chiral amino acids, chiral ammonium salts, chiral bicyclic guanidines, chiral diols, chiral imidazolidinones, chiral isothioureas, chiral n-heterocyclic carbenes (NHC), chiral oxazaborolidines, chiral sulfonic acids, cinchona alkaloids, and prolines, proline analogs. All can be used to accelerate different types of chemical reactions for research and production, whereas all are of high purity and of high-popularity among consumers.

CD Genomics Supercharges Transcriptomics Research by Digital RNA Sequencing Technology